EIF2AK1
protein-codingeukaryotic translation initiation factor 2 alpha kinase 1, the group of Eukaryotic translation initiation factor 2 alpha kinases
Gene summary
The protein encoded by this gene acts at the level of translation initiation to downregulate protein synthesis in response to stress. The encoded protein is a kinase that can be inactivated by hemin. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~36.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0030036
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0030036
Submitter: Ambry Genetics
Inheritance Pattern: Unknown
Disease ID:MONDO:0030036
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EIF2AK1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014413.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 37 | 3 | 45 | ||
| missense | 147 | 12 | 4 | 163 | ||
| nonsense | 5 | 1 | 6 | |||
| start loss | 1 | 1 | ||||
| frameshift | 3 | 3 | ||||
| splice donor/acceptor (+/-2bp) | 9 | 9 | ||||
| Total | 0 | 0 | 170 | 50 | 7 | 227 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055228.2 | 15 | MANE Select | |
| Ensembl | ENSP00000199389.6 | 15 | MANE Select | |
| RefSeq | NP_001127807.1 | 15 | Standard | |
| Ensembl | ENSP00000392734.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Influenza A - Homo sapiens (human)
- Protein processing in endoplasmic reticulum - Homo sapiens (human)
- Hepatitis C - Homo sapiens (human)
- Measles - Homo sapiens (human)
- Epstein-Barr virus infection - Homo sapiens (human)
Biological Process
- acute inflammatory response
- phagocytosis
- negative regulation of cell population proliferation
- regulation of translational initiation by eIF2 alpha phosphorylation
- regulation of eIF2 alpha phosphorylation by heme
Molecular Function
- protein kinase activity
- eukaryotic translation initiation factor 2alpha kinase activity
- ATP binding
- heme binding
- protein homodimerization activity
Cellular Component
- cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000199389
- Coding exons
- 15
- Length
- 36981
- Individuals with no LoFs
- 125700
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 48
- Defined
- 125748
- p
- 0.000191
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.434 | 312 | 334 | 0.933 | 0.0000181 | 4077 |
| Missense (PolyPhen) | 67 | 97.993 | 0.68372 | 1207 | ||
| Synonymous | -0.693 | 143 | 133 | 1.08 | 0.00000796 | 1205 |
| Loss of Function | 2.89 | 16 | 34.2 | 0.468 | 0.00000172 | 414 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00041 | 0.00040 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00028 | 0.00027 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00019 | 0.00018 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0.00050 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Inhibits protein synthesis at the translation initiation level, in response to various stress conditions, including oxidative stress, heme deficiency, osmotic shock and heat shock. Exerts its function through the phosphorylation of EIF2S1 at 'Ser- 48' and 'Ser-51', thus preventing its recycling. Binds hemin forming a 1:1 complex through a cysteine thiolate and histidine nitrogenous coordination. This binding occurs with moderate affinity, allowing it to sense the heme concentration within the cell. Thanks to this unique heme-sensing capacity, plays a crucial role to shut off protein synthesis during acute heme-deficient conditions. In red blood cells (RBCs), controls hemoglobin synthesis ensuring a coordinated regulation of the synthesis of its heme and globin moieties. Thus plays an essential protective role for RBC survival in anemias of iron deficiency. Similarly, in hepatocytes, involved in heme-mediated translational control of CYP2B and CYP3A and possibly other hepatic P450 cytochromes. May also contain ER stress during acute heme-deficient conditions (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.294
Intolerance Scores
- LoFtool
- 0.796
- RVIS EVS
- 0.36
- RVIS percentile EVS
- 74.63
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.371
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |